Registration Hours
(All times listed in ET*)
Wednesday, November 29: 3:00 PM - 6:00 PM
Thursday, November 30: 6:30 AM - 5:30 PM
Friday, December 1: 6:30 AM - 5:15 PM
Saturday, December 2: 6:30 AM - 4:30 PM
Sunday, December 3: 6:30 AM - 12:15 PM
Agenda is subject to change.
Use the Advanced Filter below to identify the tracks that are of interest.
*All Credits are pending approval for COPE, FL Board Optometry, FL Board Opticianry, TX Board of Optometry.
*Note: The CEE, or Transcript Quality (TQ), courses are noted by the (CEE) tag. You can sort by this tag under Advanced Filters.
COPE: 87982-SD
TX Board- Optometry: 20-1122452
Ocular hypertension is generally thought of a precursor to glaucoma. The understanding of various risk factors through the Ocular Hypertension Treatment Study (OHTS) is fundamental to our treatment and management of this condition. With the advent of Optical Coherence Tomography (OCT) we gained further insight into effective management of this ocular hypertension. The clinical paradigm has shifted over the years in what testing to perform, how frequently patients need to be seen, and when to initiate as well as escalate treatment. In this course we will review the proper definition, causes and most up-to-date treatment and management of ocular hypertension.
COPE: 87962-GL
TX Board- Optometry: 20-1122454
Optometrists remain the first line of defense for the majority of glaucoma suspects and glaucoma patients that prevent for comprehensive exams. With the advent of new medications over the last five years and the number of patients with glaucoma increasing as baby boomers are getting older, it is imperative to understand the medication profiles including side effects and potential adverse effects with glaucoma medications especially given several co-morbidities that may be present in this patient population. Rather than having a one size fits all approach, it is important to decide a treatment plan on an individual basis. In this course we will review the mechanisms of actions of the medications, proper techniques in measuring intraocular pressure and both the conventional and unconventional drainage systems of aqueous humor. We will go through several clinical cases to enhance understanding using real-life examples.
COPE: 87806-GO
TX Board- Optometry: 20-1125508
COPE: 87830-NO
TX Board- Optometry: 20-1123802
COPE: 87817-NO
TX Board- Optometry: 20-1123804
COPE: 87812-SD
This session will consider the epidemics of diabetes and diabetic retinopathy via a series of illustrative patient case examples. Accepted and novel strategies for prevention and treatment of both will be discussed.
Objectives:
- Attendees will be able to list newer technologies that assist with grading structural severity of diabetes-related retinal disease
- Attendees will be able to list newer technologies that assist with grading functional severity of diabetes-related retinal disease
- Attendees will be able to describe multiple environmental contributants to the diabetes epidemic
- Attendees will be able to describe newer systemic diabetes therapies that afford cardio-renal protection in type 2 diabetes and which patients are most likley to benefit
- Attendees will be able to list and recommend a variety of patient-centered strategies for prevention of diabetes
- Systemic Disease (SD)
COPE: 87840-SD
TX Board- Optometry: 20-1123810
This course will cover the perils of sugar in the American diet including the formation of advanced glycation end products (AGEs) that are implicated in multiple diseases. The link between added sugars and the most important systemic diseases facing society and strategies for mitigating this risk will be considered.
Objectives:
- Attendees will be able to describe the epidemiolgical link between added dietary sugars and diabetes, cardiovascular disease and cancer
- Attendees will be able to explain biological mechanisms linking sugar intake to diabetes, heart disease and cancer risk
- Attendees will learn to critically assess the scientific literature with regard to sugar intake and onset of multiple diseases
- Attendees will be able to enumerate lifestyle strategies that reduce the risk of major systemic diseases
- Attendees will be able to list systemic and ocular diseases directly linked to the formation of irrversible glyco-protein aggregates (AGEs)
- Systemic Disease (SD)
